Post-treatment for Stage I Breast Cancer?
Hello Doctor, my wife was diagnosed with breast cancer earlier this year at the age of 42.
The pathology report after surgery is as follows: ER: 98+ PR: 98+ Her2: 2+ FISH: Negative Ki67: 9% Tumor size: 1.9 cm.
During lymph node surgery, 4 nodes were removed and tested, with no metastasis found.
A full-body examination showed no signs of metastasis.
I would like to ask the following:
1.
The attending physician informed us that chemotherapy is not necessary and that taking Tamoxifen for five years is sufficient.
They mentioned that if we are concerned, we could consider genetic testing.
Would you recommend doing that? Will not undergoing chemotherapy increase the risk of recurrence?
2.
If chemotherapy is not administered, would you recommend adding an aromatase inhibitor or ovarian suppression therapy?
3.
The doctor mentioned that there are some residual cancer cells found, with a small amount reaching the underlying muscle, but they do not plan to perform a second surgery and will proceed with radiation therapy instead.
Does this indicate metastasis? Can radiation therapy completely eliminate the residual cancer cells? Why is the physician reluctant to perform another surgery to remove all the cancer?
4.
The doctor stated that my wife's cancer cells are well-behaved and classified as Luminal A, with a low risk of recurrence.
If she takes good care of herself, what is the estimated recurrence rate?
5.
Are there any specific dietary or lifestyle considerations we should be aware of? The doctor seems to be in a hurry during appointments (likely due to a high patient volume), and I have not been able to ask all my questions clearly.
I would appreciate your guidance.
Thank you!
Niming, 40~49 year old female. Ask Date: 2023/03/21
Dr. Hu Ziren reply Oncology
According to the report, the type of breast cancer is associated with a low risk of recurrence.
It is recommended to follow the attending physician's advice to take Tamoxifen for 5-10 years and undergo postoperative radiotherapy, with regular follow-ups.
There are no dietary restrictions or lifestyle contraindications.
Reply Date: 2023/03/21
More Info
Post-surgery treatment options for Stage I breast cancer, particularly in the context of your wife's diagnosis, involve several key considerations that can significantly influence her prognosis and quality of life. Based on the details provided, let's address your questions systematically.
1. Chemotherapy and Genetic Testing: Your wife's pathology report indicates she has hormone receptor-positive breast cancer (ER: 98+, PR: 98+) with a HER2 score of 2+ and a Ki67 of 9%. Given these factors, her oncologist has recommended against chemotherapy, suggesting that five years of Tamoxifen (an estrogen receptor modulator) is sufficient. The decision to forgo chemotherapy is often based on the low risk of recurrence associated with hormone receptor-positive cancers, especially when lymph nodes are negative for metastasis. However, if there are concerns about her individual risk factors or family history, genetic testing (such as BRCA1/2 testing) could provide additional insights into her risk of recurrence and guide treatment decisions. If she has a family history of breast or ovarian cancer, genetic testing is particularly advisable.
2. Hormonal Therapy and Ovarian Suppression: If your wife is premenopausal, the addition of ovarian suppression (such as with GnRH agonists) may be considered to enhance the effectiveness of Tamoxifen. This approach can lower estrogen levels further, potentially reducing the risk of recurrence. However, this decision should be made in consultation with her oncologist, considering her overall health, preferences, and the potential side effects of ovarian suppression.
3. Residual Cancer Cells and Radiation Therapy: The presence of residual cancer cells, particularly if they are noted to be at the margins of the excised tissue, raises concerns about the potential for local recurrence. Radiation therapy is typically recommended in such cases to target any remaining cancer cells and reduce the risk of recurrence. While radiation can significantly decrease the likelihood of local recurrence, it may not guarantee the complete eradication of all residual cancer cells. The decision not to perform a second surgery may be based on the assessment that the benefits of additional surgery do not outweigh the risks, especially if radiation therapy is expected to be effective.
4. Recurrence Risk: Your wife's cancer being classified as Luminal A (based on the hormone receptor positivity and low Ki67) suggests a lower risk of recurrence compared to more aggressive subtypes. While her oncologist has indicated a low recurrence risk, it is essential to understand that no cancer is entirely without risk. The estimated recurrence rate can vary widely based on individual factors, including age, overall health, and adherence to treatment. Regular follow-ups and monitoring are crucial for early detection of any potential recurrence.
5. Lifestyle Considerations: Post-treatment, maintaining a healthy lifestyle can play a role in overall well-being and potentially influence cancer recurrence. This includes a balanced diet rich in fruits, vegetables, whole grains, and lean proteins, regular physical activity, maintaining a healthy weight, and avoiding tobacco and excessive alcohol consumption. Additionally, managing stress through mindfulness, yoga, or other relaxation techniques can be beneficial. It’s also important for her to stay informed about her health and to communicate openly with her healthcare team about any concerns or symptoms.
In conclusion, while your wife's prognosis appears favorable based on her pathology report, ongoing communication with her healthcare team is vital. Regular follow-ups, adherence to prescribed therapies, and lifestyle modifications can all contribute to her long-term health and well-being. If you have further questions or concerns, consider scheduling a dedicated appointment with her oncologist to discuss these topics in detail.
Similar Q&A
Post-Surgery Treatment Options for Stage 0 Breast Cancer Patients
Dear Doctor: For a patient with stage 0 carcinoma in situ (tumor size 3 cm, postoperative lymph node involvement less than 1%, chromosomal abnormalities 1-9%) who has undergone a total mastectomy, is there still a need for further treatment (such as 5 years of medication or radia...
Dr. Chen Junyi reply Oncology
It may depend on the status of the hormone receptors.[Read More] Post-Surgery Treatment Options for Stage 0 Breast Cancer Patients
Understanding Breast Cancer Surgery and Post-Operative Treatment Options
Hello Doctor, My mother has been undergoing regular mammograms every six months and was diagnosed with breast cancer last week. The tumor is located at the 9 o'clock position in the right breast, measuring 1.2 cm, and is a single tumor (the doctor mentioned that lymph node...
Dr. Lai Yicheng reply Oncology
Dear Madam, Thank you for your letter. Here are my responses: 1. If the malignant tumor is small, partial resection followed by adjuvant radiation therapy can be considered. However, if your mother has multiple benign fibromas in both breasts as you described, total mastectomy ...[Read More] Understanding Breast Cancer Surgery and Post-Operative Treatment Options
Understanding Post-Surgery Treatment Options for Breast Cancer
Your mother is currently sixty years old and underwent a left mastectomy on December 21, 2015. The tumor measured 0.7 cm with no lymph node metastasis, and testing revealed HER2+++ which is considered positive. The physician has recommended chemotherapy along with hormone therapy...
Dr. Lai Yicheng reply Oncology
Ms. Han: 1. Your mother has a left breast cancer tumor measuring 0.7 cm, with no lymph node metastasis. Her2 is 3+ (positive), estrogen receptor positive (+, 10%), and progesterone receptor positive (+, 40%). She underwent a left mastectomy on December 21, 2015. 2. According to t...[Read More] Understanding Post-Surgery Treatment Options for Breast Cancer
Understanding Early Stage Breast Cancer: Treatment Options and Concerns
My mother has stage I breast cancer with a 1.4 cm tumor. After the doctor removed it and confirmed the diagnosis, the surgeon initially only removed half of the tumor, but at my mother's request, the remaining part was also removed. Will this cause the cancer cells to spread...
Dr. Zhao Ming reply Breast and Thyroid
1. Generally, this is a standard treatment approach and does not lead to the spread of breast cancer. 2. The survival rate for breast cancer primarily depends on the malignancy of the individual cancer cells rather than the treatment method (chemotherapy can improve survival ra...[Read More] Understanding Early Stage Breast Cancer: Treatment Options and Concerns
Related FAQ
(Surgery)
Axillary(Surgery)
Fibroadenoma(Surgery)
Breast Adenoma(Oncology)
Cancer Treatment(Oncology)
Fibrocystic Breast Disease(Surgery)
Postoperative Care(Surgery)
Breast Size(Surgery)
Breast Reduction Surgery(Plastic Surgery)
Accessory Breast(Surgery)